On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Sunday, March 29, 2009

Jadad Scale to assess the quality of clinical trials

›
In a cost-effectiveness assessment report, a detail descriptions were provided for the approaches in choosing the clinical trial data for me...

Stratified randomization to achieve the balance of treatment assignment within each strata

›
Stratified randomization refers to the situation in which strata are constructed based on values of prognostic variables or baseline covaria...
1 comment:
Saturday, March 28, 2009

Too good to be true?

›
Typically, the regulatory authority requires two pivotal studied to demonstrate the efficacy. If the results from two studies show the confl...
Wednesday, March 18, 2009

Should expected clinical outcomes of the disease under study, which are efficacy endpoints, be reported as AEs/SAEs?

›
The paragraphs below are from the following website: http://firstclinical.com/journal/2008/0806_GCP35.pdf Some protocols instruct investigat...

Adverse events (AE), treatment emergent adverse events (TEAE), and adverse drug reaction (ADR)

›
There is some debate and inconsistencies regarding the definition of Adverse Drug Reactions. If you call it an adverse event, you may not ha...
28 comments:
Friday, March 06, 2009

What is the easiest way to start a meta analysis?

›
I used Revman program to do my meta analysis and generated the nice Forest plot two years ago. It worked for me very well at that time. Revm...

Biosimilar, Follow-up Biologics, Biogenerics, and Generic Biologics

›
Biosimilars or Follow-on biologics are terms used to describe officially approved new versions of innovator biopharmaceutical products, foll...
Sunday, March 01, 2009

iDMC, iSTAT, iDM, and more

›
I guess that the iDMC (stands for independent Data Monitoring Committee) has been used for a while, however, I first time heard the terms iS...
1 comment:
Saturday, February 28, 2009

Liability and Indemnification of data monitoring committee members

›
As stated in Demets ' paper "Liability issues for data monitoring committee members" (Clinical Trials 2004; 1: 525–531): In ra...
Friday, February 27, 2009

Confidence interval for correlation coefficient

›
When we perform the correlation analysis, we typically calculate the correlation coefficient and then test if this correlation coefficient i...
Thursday, February 19, 2009

Most testing for US drug industry's late-stage human trials done outside the country, study indicates

›
The Wall Street Journal (2/19, Wang) reports, "Most testing for the US drug industry's late-stage human trials is now done at site...
Saturday, February 14, 2009

Evidence-based medicine - the Evidence Gap

›
New York Times had a series of articles to explore medical treatments used despite scant proof they work and examining steps toward medicine...

Cronbach's alpha - reliability coefficient

›
Cronbach's Alpha is a tool for assessing the reliability of scales (for example a quality of life instrument). Cronbach's alpha can ...
Thursday, February 12, 2009

Blood plasma and serum

›
Blood plasma, or plasma, is prepared by obtaining a sample of blood and removing the blood cells. The red blood cells and white blood cells ...
Thursday, February 05, 2009

DMC (Data Monitoring Committee) vs. DSMB (Data Safety Monitoring Board)

›
DMC (Data Monitoring Committee) vs. DSMB (Data Safety Monitoring Board) are the same thing. The term DMC is used more now because it is the ...
Tuesday, February 03, 2009

Standard Error of Mean vs. Standard Error of Measurement

›
Everybody with basic statistical knowledge should understand the differences between the standard deviation (SD) and the standard error of m...
2 comments:
Tuesday, January 20, 2009

Multiple Comparisons

›
In statistics or biostatistics, the multiple comparisons problem occurs when one considers a set, or family, of statistical inferences simul...
1 comment:
Monday, January 19, 2009

Trial Biomarker Analysis More Than Data Dredging

›
members of the FDA's oncology Drugs Advisory Committee cautioned sponsors against treating retrospective clinical trial biomarker analys...

Data dredging vs. Data mining; Post-hoc vs. Ad-hoc

›
Data dredging (data fishing, data snooping) is the inappropriate (sometimes deliberately so) search for 'statistically significant'...
2 comments:
Sunday, January 11, 2009

EQ-5D

›
EQ-5D is a standardized instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments, i...
‹
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.